DK2007882T3 - Fremgangsmåde til fremstilling af differentierede aviære celler og gener involveret i opretholdelse af pluripotens - Google Patents

Fremgangsmåde til fremstilling af differentierede aviære celler og gener involveret i opretholdelse af pluripotens

Info

Publication number
DK2007882T3
DK2007882T3 DK07727050.2T DK07727050T DK2007882T3 DK 2007882 T3 DK2007882 T3 DK 2007882T3 DK 07727050 T DK07727050 T DK 07727050T DK 2007882 T3 DK2007882 T3 DK 2007882T3
Authority
DK
Denmark
Prior art keywords
avian
stem cells
differentiated
pluripotency
maintenance
Prior art date
Application number
DK07727050.2T
Other languages
English (en)
Inventor
Bertrand Pain
Fabrice Lavial
Jacques Samarut
Original Assignee
Agronomique Inst Nat Rech
Centre Nat Rech Scient
Ens Ecole Normale Superieure De Lyon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech, Centre Nat Rech Scient, Ens Ecole Normale Superieure De Lyon filed Critical Agronomique Inst Nat Rech
Application granted granted Critical
Publication of DK2007882T3 publication Critical patent/DK2007882T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK07727050.2T 2006-03-24 2007-03-19 Fremgangsmåde til fremstilling af differentierede aviære celler og gener involveret i opretholdelse af pluripotens DK2007882T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602597A FR2898908A1 (fr) 2006-03-24 2006-03-24 Procede de preparation de cellules aviaires differenciees et genes impliques dans le maintien de la pluripotence
PCT/EP2007/052572 WO2007110341A1 (fr) 2006-03-24 2007-03-19 Procede de preparation de cellules aviaires differenciees et genes impliques dans le maintien de la pluripotence

Publications (1)

Publication Number Publication Date
DK2007882T3 true DK2007882T3 (da) 2010-12-20

Family

ID=37055981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07727050.2T DK2007882T3 (da) 2006-03-24 2007-03-19 Fremgangsmåde til fremstilling af differentierede aviære celler og gener involveret i opretholdelse af pluripotens

Country Status (11)

Country Link
US (1) US20090311789A1 (da)
EP (2) EP2007882B1 (da)
JP (1) JP5124748B2 (da)
AT (1) ATE479744T1 (da)
AU (1) AU2007229556A1 (da)
CA (1) CA2647806A1 (da)
DE (1) DE602007008863D1 (da)
DK (1) DK2007882T3 (da)
ES (1) ES2351620T3 (da)
FR (1) FR2898908A1 (da)
WO (1) WO2007110341A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2643463B1 (en) * 2010-11-23 2017-09-27 CuRNA, Inc. Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
FR3008992A1 (fr) * 2013-07-25 2015-01-30 Agronomique Inst Nat Rech Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
JP2016158577A (ja) * 2015-03-03 2016-09-05 富士フイルム株式会社 細胞コロニー検出装置および方法並びにプログラム
JP6925931B2 (ja) 2017-10-20 2021-08-25 日本スピンドル製造株式会社 バッチ式の混練機、及びバッチ式の混練機における羽根部の交換方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456357A (en) 1994-07-07 1995-10-10 Wenner; John W. Nestable bucket and carrier
FR2726003B1 (fr) * 1994-10-21 2002-10-18 Agronomique Inst Nat Rech Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
US5914268A (en) 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
KR20010042069A (ko) 1998-03-20 2001-05-25 베니텍 오스트레일리아 리미티드 유전자 발현 조절방법
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
DE10160151A1 (de) 2001-01-09 2003-06-26 Ribopharma Ag Verfahren zur Hemmung der Expression eines vorgegebenen Zielgens
DE10100586C1 (de) 2001-01-09 2002-04-11 Ribopharma Ag Verfahren zur Hemmung der Expression eines Ziegens
EP1272630A2 (en) 2000-03-16 2003-01-08 Genetica, Inc. Methods and compositions for rna interference
CA2403162A1 (en) 2000-03-17 2001-09-27 Benitec Australia Ltd. Genetic silencing
PT1309726E (pt) 2000-03-30 2010-03-08 Whitehead Biomedical Inst Mediadores de interferência por rna específicos de sequência de rna
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
KR100909681B1 (ko) 2000-12-01 2009-07-29 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. Ｒｎａ 간섭을 매개하는 작은 ｒｎａ 분자
WO2003035869A1 (de) 2001-10-26 2003-05-01 Ribopharma Ag Verwendung einer doppelsträngigen ribonukleinsäure zur gezielten hemmung der expression eines vorgegebenen zielgens
CA2452653A1 (en) 2001-07-17 2003-01-30 Anne Josephine Milner Silencing of gene expression by sirna
US20030198627A1 (en) 2001-09-01 2003-10-23 Gert-Jan Arts siRNA knockout assay method and constructs
DE10163098B4 (de) 2001-10-12 2005-06-02 Alnylam Europe Ag Verfahren zur Hemmung der Replikation von Viren
JP2005512976A (ja) 2001-10-26 2005-05-12 リボファーマ アーゲー Ｒｎａ干渉により線維化疾患を処置するための医薬
WO2003035870A1 (de) 2001-10-26 2003-05-01 Ribopharma Ag Medikament zur behandlung eines pankreaskarzinoms
CN1608133A (zh) 2001-10-26 2005-04-20 里伯药品公司 双链核糖核酸用于治疗正(+)链rna病毒感染的用途
DE10230996A1 (de) 2001-10-26 2003-07-17 Ribopharma Ag Medikament zur Behandlung eines Pankreaskarzinoms
BRPI0313202A8 (pt) 2002-08-05 2016-08-16 Atugen Ag Formas adicionais para interferir com as moléculas de rna
DK1536827T3 (da) 2002-08-14 2009-04-20 Silence Therapeutics Ag Anvendelse af proteinkinase N-beta
WO2004035615A2 (en) 2002-10-18 2004-04-29 Atugen Ag Factor involved in metastasis and uses thereof
US20050043263A1 (en) 2003-06-27 2005-02-24 Atugen Ag Use of double-stranded ribonucleic acid for inducing cell lysis

Also Published As

Publication number Publication date
AU2007229556A1 (en) 2007-10-04
JP5124748B2 (ja) 2013-01-23
CA2647806A1 (fr) 2007-10-04
EP2007882B1 (fr) 2010-09-01
EP2007882A1 (fr) 2008-12-31
EP2292739A1 (fr) 2011-03-09
US20090311789A1 (en) 2009-12-17
ATE479744T1 (de) 2010-09-15
WO2007110341A1 (fr) 2007-10-04
ES2351620T3 (es) 2011-02-08
EP2292739B1 (fr) 2012-09-12
JP2009529899A (ja) 2009-08-27
DE602007008863D1 (de) 2010-10-14
FR2898908A1 (fr) 2007-09-28

Similar Documents

Publication Publication Date Title
Lin et al. Identification of miRNAs and their targets in the liverwort Marchantia polymorpha by integrating RNA-Seq and degradome analyses
Tsuzuki et al. Profiling and characterization of small RNAs in the liverwort, Marchantia polymorpha, belonging to the first diverged land plants
RU2017128034A (ru) Новый промотор и пути его применения
BRPI0814781A8 (pt) ''proteína, sequência de ácido nucleico, método para a produção de ácido itacônico, vetor, célula hospedeira, e, uso de um ácido cis-aconítico descarboxilase''
AR090417A1 (es) Plantas resistentes al glifosato y metodos asociados
RU2012103038A (ru) Введение днк в растительные клетки
WO2008140615A3 (en) Modified messenger rna stabilizing sequences for expressing genes in bacterial cells
MY156855A (en) Novel regulatory elements
WO2012014207A3 (en) Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
MX2023009165A (es) Promotores especificos de tricoma para la manipulacion de cannabinoides y otros compuestos en tricomas glandulares.
JP2012503478A5 (da)
UY31875A (es) Novedosos genes involucrados en la biosíntesis
MX2008000200A (es) Polinucleotidos que codifican enzimas que modifican el isoprenoide y sus metodos de uso.
PH12012502520A1 (en) Plants having enhanced yield-related traits and method for making the same
WO2007132193A8 (en) Modified vird2 protein and its use in improved gene transfer
BRPI0815392A2 (pt) Método para produzir planta transgênica, planta transgênica, uso de uma sequência de ácido nucleico exógeno, gene quimérico, vetor de transformação de planta, e , planta ou célula de planta.
ATE555196T1 (de) Wärmebeständige duplexspezifische nuklease
WO2009069381A1 (ja) フラビンアデニンジヌクレオチド結合型グルコース脱水素酵素遺伝子が導入された形質転換体、及び該形質転換体を用いたフラビンアデニンジヌクレオチド結合型グルコース脱水素酵素の製造法
WO2013065046A8 (en) Isolated polynucleotides and polypeptides, transgenic plants comprising same and uses thereof in improving abiotic stress tolerance, nitrogen use efficiency, biomass, vigor or yield of plants
WO2014059275A3 (en) Process for producing gougerotin employing streptomyces microflavus strains
EA201070229A1 (ru) Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения
DK2007882T3 (da) Fremgangsmåde til fremstilling af differentierede aviære celler og gener involveret i opretholdelse af pluripotens
WO2005085449A3 (en) Stomatal guard cell specific promoter
JPWO2022138964A5 (da)
WO2010080782A3 (en) Random homozygous gene perburbation (rhgp) with thermal assymetric interlaced (tail)-pcr